Greg Gregory, PhD | Executive VP, Partner
Cynthia Miller, MD, MPH, FACP | VP, Medical Director, Access Experience Team
Christopher Terrone | VP, Healthcare Insights, Market Access
Artificial intelligence (AI) is significantly transforming the healthcare sector, evolving from a tool used to streamline administrative tasks to one influencing essential clinical functions. For pharmaceutical manufacturers, understanding how their health system customers are using AI is crucial.
The adoption of AI can standardize care, modify drug utilization patterns, and ultimately shift market share. How Health Systems are Using AI in Clinical Decision-Making is a groundbreaking report that offers invaluable insights to help pharmaceutical companies understand and navigate this shift.
The findings are derived from a survey of 25 decision-makers who are leading the deployment of their health systems’ AI initiatives.
By understanding the trends and actions of health systems, pharmaceutical companies can shift their perspective from viewing AI as merely a tech trend to mapping it as an emerging factor driving patient care, medication access, and partnerships.
Want to see more examples, data, and strategies? Fill out the form below to access the complete report.